A
Adriano Arguedas
Researcher at Pfizer
Publications - 98
Citations - 3801
Adriano Arguedas is an academic researcher from Pfizer. The author has contributed to research in topics: Otitis & Streptococcus pneumoniae. The author has an hindex of 31, co-authored 91 publications receiving 3492 citations. Previous affiliations of Adriano Arguedas include Boston Children's Hospital & University of Costa Rica.
Papers
More filters
Journal ArticleDOI
Global and regional burden of hospital admissions for severe acute lower respiratory infections in young children in 2010: a systematic analysis
Harish Nair,Harish Nair,Eric A. F. Simões,Igor Rudan,Bradford D. Gessner,Eduardo Azziz-Baumgartner,Jian Shayne F Zhang,Daniel R. Feikin,Daniel R. Feikin,Grant A. Mackenzie,Jennifer C Moiïsi,Anna Roca,Henry C. Baggett,Syed M. A. Zaman,Syed M. A. Zaman,Rosalyn J. Singleton,Marilla G. Lucero,Aruna Chandran,Angela Gentile,Cheryl Cohen,Anand Krishnan,Zulfiqar A Bhutta,Adriano Arguedas,Alexey Clara,Ana Lucia Andrade,Maurice Ope,Raúl Ruvinsky,María Hortal,John P. McCracken,Shabir A. Madhi,Nigel Bruce,Shamim Qazi,Saul S. Morris,Shams El Arifeen,Martin Weber,J. Anthony G. Scott,W. Abdullah Brooks,Robert F. Breiman,Harry Campbell +38 more
TL;DR: The data suggest that although 62% of children with severe ALRI are treated in hospitals, 81% of deaths happen outside hospitals, which suggests community-based management of severe disease could be an important complementary strategy to reduce pneumonia mortality and health inequities.
Journal ArticleDOI
Pharmacokinetics and Safety of Intravenous Voriconazole in Children after Single- or Multiple-Dose Administration
Thomas J. Walsh,Mats O. Karlsson,Timothy A. Driscoll,Adriano Arguedas,Peter C. Adamson,Xavier Sáez-Llorens,Ajay Vora,Antonio Arrieta,Jeffrey L. Blumer,Irja Lutsar,Peter A. Milligan,Nolan Wood +11 more
TL;DR: It is concluded that pediatric patients have a higher capacity for elimination of voriconazole per kilogram of body weight than do adult healthy volunteers and that dosages of 4 mg/kg may be required in children to achieve exposures consistent with those in adults following dosage of 3mg/kg.
Journal ArticleDOI
Otitis media and its consequences: beyond the earache
Anne Vergison,Ron Dagan,Adriano Arguedas,Jan Bonhoeffer,Robert Cohen,Ingeborg Dhooge,Alejandro Hoberman,Johannes G. Liese,Paola Marchisio,A. A. Palmu,G. Thomas Ray,Elisabeth A. M. Sanders,Eric A. F. Simões,Matti Uhari,Johan Van Eldere,Stephen I. Pelton +15 more
TL;DR: An international group of multidisciplinary experts on middle-ear and paediatric infections met to explore where consensus exists on the management of acute otitis media and to propose to clinicians and public health officials their views on the actions needed to be taken to reduce the disease burden and the microbial antibiotic resistance.
Journal ArticleDOI
Bacteriologic and clinical efficacy of high dose amoxicillin/clavulanate in children with acute otitis media.
Ron Dagan,Alejandro Hoberman,Candice E. Johnson,Eugene Leibovitz,Adriano Arguedas,Faina V. Rose,Brian Wynne,Michael R. Jacobs +7 more
TL;DR: It was found that high dose amoxicillin/clavulanate was highly efficacious in children with AOM, including those most likely to fail treatment, namely children <24 months of age and those with infections caused by PRSP.
Journal ArticleDOI
Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines.
TL;DR: It is demonstrated that the most common pneumococcal serotypes causing AOM globally are 3, 6A, 6B, 9V, 14, 19A, 19F, and 23F.